TABLE I.
PEMT Met212Val Genotype and Risk of Spina Bifida
| Genotype | Cases (%) | Controls (%) | OR (95% CI) |
|---|---|---|---|
| Overall | |||
| Met212/Met212 | 150 (44.4) | 240 (43.3) | Referent |
| Met212/Val212 | 144 (42.6) | 222 (40.1) | 1.04a (0.78, 1.39) |
| Val212/Val212 | 44 (13.0) | 92 (16.6) | 0.77a (0.51, 1.16) |
| Non-Hispanic white | |||
| Met212/Met212 | 63 (50.4) | 148 (53.8) | Referent |
| Met212/Val212 | 55 (44.0) | 108 (39.3) | 1.20 (0.77–1.86) |
| Val212/Val212 | 7 (5.6) | 19 (6.9) | 0.87 (0.35–2.16) |
| Hispanic white | |||
| Met212/Met212 | 69 (39.9) | 77 (38.5) | Referent |
| Met212/Val212 | 75 (43.3) | 84 (42.0) | 1.0 (0.64–1.56) |
| Val212/Val212 | 29 (16.8) | 39 (19.5) | 0.83 (0.46–1.48) |
Odds ratio adjusted to ethnicity group.